NFL concussion settlement claims approvals exceed $380 million in first year; value surpasses NFL’s five-year estimate

Philadelphia, PA – More than $380 million in monetary awards have been approved as part of the NFL concussion settlement since the claims process opened one year ago, according to the latest report released yesterday by the Court-appointed Claims Administrator. The NFL, in a report submitted to the court as part of the settlement approval process, […]

March 28, 2018

football

Philadelphia, PA – More than $380 million in monetary awards have been approved as part of the NFL concussion settlement since the claims process opened one year ago, according to the latest report released yesterday by the Court-appointed Claims Administrator. The NFL, in a report submitted to the court as part of the settlement approval process, had estimated it would pay $298 million in the first five years of the settlement. In addition, more than 5,500 Baseline Assessment Program appointments have been scheduled, with more than 3,900 attended.

“The concussion settlement is on track to cost the NFL far more than it projected, and former players are receiving the benefits they are entitled to and deserve. The ever-increasing number of claims that are being approved totaling hundreds of millions of dollars show that the NFL concussion settlement is fulfilling its promise,” said Christopher Seeger, co-lead class counsel for the retired NFL players.

As noted in news reports, earlier delays–which were the result of a large influx of claims when the program began–are being more quickly resolved. Earlier this month, the Court approved two new physicians to the Appeals Advisory Panel (AAP), which is responsible for reviewing claims that involve diagnoses received before the effective date of the settlement.

Additionally, the large number of initial claims included many that required further investigation by the Claims Administrator to ensure the settlement is being implemented fairly and without fraud. For example, the Court-appointed Special Masters disqualified one physician who reviewed 153 claims after her “examinations” were found to not meet the standard of care. According to their report, some former players were sent cross-country to visit this physician, who also claimed to have conducted 134.5 hours of examinations during one 48-hour period. Affected former players will be allowed to seek new evaluations. Other court documents revealed text messages in which a representative from a company claiming to help with the settlement process informed a former NFL player that “we train you for the test.”

The Claims Administrator publishes an updated report weekly, which can be found at NFLConcussionSettlement.com.

Related News

March 30, 2026
Ten Seeger Weiss Attorneys Named To The 2026 Lawdragon 500 Leading Plaintiff Financial Lawyers Guide

Seeger Weiss is proud to announce that ten Seeger Weiss attorneys have been selected for inclusion in The 2026 Lawdragon 500 Leading Plaintiff Financial Lawyers guide. Congratulations to Christopher Seeger, Stephen Weiss, Parvin K. Aminolroaya, Ben Barnett, David R. Buchanan, Steven Daroci, Shauna Itri, Jeremy Kasha, Jennifer Scullion, and Caleb Seeley on this well-deserved recognition. […]

Read More
March 26, 2026
Jury Finds Meta and YouTube Liable in Landmark California Social Media Addiction Trial

A California jury has found Meta and YouTube negligent in designing platforms that harmed a young user, ordering Meta to pay $4.2 million and YouTube to pay $1.8 million in combined compensatory and punitive damages, in what is being called a landmark verdict in social media addiction litigation. Seeger Weiss Founding Partner Christopher Seeger serves […]

Read More
March 12, 2026
Seeger Weiss Partner Parvin Aminolroaya and Counsel Max Kelly Appointed to Leadership Roles in GLP-1 NAION Products Liability Litigation

Seeger Weiss is proud to announce that Partner Parvin Aminolroaya has been appointed Co-Lead Counsel for Plaintiffs in the In Re: GLP-1 RAS Non-arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation and Counsel Max Kelly has been appointed to the Plaintiffs’ Executive Committee. The litigation involves claims that GLP-1 receptor agonist drugs including Ozempic, Wegovy, […]

Read More